Thus, these observations support the assertion that HER4 expression is regulated by NRF2 and may also be a contributing determinant and basis of cellular sensitivity and response (susceptibility and resistance) of some cancers to ERL and perhaps to LAP. This evidence concerns the gene ERBB4 and cancer.